STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Not yet recruiting
- Ovarian Neoplasms
- Combined Oral Contraceptive
- Progestin
- (no location specified)
2022-02-08
Feb 8, 2022N
Completed
- Ovarian Cancer
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022T
Recruiting
- Ovarian Cancer
- +5 more
- TTI-622
- Pegylated Liposomal Doxorubicin
- Houston, TexasOncology Consultants, P.A.
2022-03-14
Mar 14, 2022U
Recruiting
- Ovarian Cancer
- +3 more
- Bristol, United KingdomUniversity Hospitals Bristol and Weston NHS Trust
2021-07-09
Jul 9, 2021C
Recruiting
- Ovarian Neoplasms
- Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
2022-03-12
Mar 12, 2022S
Not yet recruiting
- Ovarian Neoplasms
- Olaparib mono-maintenance therapy
- (no location specified)
2021-12-08
Dec 8, 2021A
Completed
- Ovarian Neoplasms
- +2 more
- p16INK4a Recombinant Rabbit Monoclonal Antibody (RM267)
- Ki67 antibody (DAKO) for malignant cases only
- Assiut, EgyptAssiut University
2021-08-12
Aug 12, 2021S
Active, not recruiting
- Ovarian Neoplasms
- (no location specified)
2021-03-16
Mar 16, 2021F
Recruiting
- Ovarian Neoplasms
- Abnormal Ovarian Ultrasound
- Lexington, KentuckyMarkey Cancer Center, University of Kentucky
2021-09-09
Sep 9, 2021M
Completed
- Ovarian Neoplasms
- Pembrolizumab
- (no location specified)
2022-02-23
Feb 23, 2022M
Recruiting
- Ovarian Neoplasms
- +8 more
- Montreal, Quebec, Canada
- +1 more
2021-10-14
Oct 14, 2021N
Active, not recruiting
- Ovarian Neoplasms
- Singapore, SingaporeNational Cancer Centre Singapore
2021-04-27
Apr 27, 2021A
Recruiting
- Ovarian Neoplasms
- +3 more
- AK112 low dose
- +2 more
- Beijing, Beijing, ChinaChinese Academy of Medical Sciences and Peking Union Medical Col
2021-08-02
Aug 2, 2021i
Recruiting
- Ovarian Cancer
- +6 more
- Physician's choice according to patient's needs.
- Multiple Locations, GermanyMultiple sites all over Germany
2021-12-01
Dec 1, 2021B
Recruiting
- Ovarian Sex Cord Stromal Tumor
- +2 more
- Paclitaxel
- +4 more
- Jinan, Shandong, ChinaQilu Hospital of Shandong University
2021-10-07
Oct 7, 2021B
Terminated
- Ovarian Cancer
- Ovarian Neoplasms
- 18F-EF5 PET/CT scan
- Optional biopsy
- Vancouver, British Columbia, CanadaBC Cancer Agency - Vancouver Centre
2022-02-02
Feb 2, 2022U
Completed
- Ovarian Cancer
- Seattle, WashingtonUniversity of Washington
2022-02-02
Feb 2, 2022N
Not yet recruiting
- Peritoneal Carcinomatosis
- +7 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022F
Recruiting
- Ovarian Cancer
- staging surgery
- Banqiao, New Taipei, TaiwanDepartment of Obstetrics and Gynecology, Far-Eastern Memorial Ho
2022-02-07
Feb 7, 2022B
Recruiting
- Ovarian Germ Cell Cancer
- +2 more
- Paclitaxel
- +4 more
- Jinan, Shandong, ChinaQilu Hospital of Shandong University
2021-10-07
Oct 7, 2021N
Not yet recruiting
- Epithelial Ovarian Cancer
- HIPEC
- Goyang-si, Gyeonggi-do, Korea, Republic ofMyong Cheol Lim
2022-03-30
Mar 30, 2022A
Recruiting
- Ovarian Cancer
- +2 more
- HIPEC
- +2 more
- Kansas City, KansasThe University of Kansas Cancer Center
2022-01-21
Jan 21, 2022D
Completed
- Ovarian Cancer
- Ovarian Neoplasms
- Atezolizumab
- +3 more
- Baltimore, Maryland
- +2 more
2021-08-10
Aug 10, 2021T
Recruiting
- Ovarian Cancer Recurrent
- microtransplantation, HLA-mismatched donor peripheral stem cell infusion
- Beijing, Beijing, ChinaThe third medical center of PLA General Hospital
2021-10-26
Oct 26, 2021A
Completed
- Ovarian Neoplasms
- Melbourne, Victoria, Australia
- +3 more
2021-09-22
Sep 22, 2021